Scotland · NHS Scotland MSAN
Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for
MSAN(2024)10 · Level 2 · issued 28 Mar 2024
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| Valid until: being discontinued, stock exhausted by the end of May 2024 | Discontinued | — |
| filled disposable devices are being discontinued with remaining stock exhausted by the end of | Discontinued | — |
| filled pens remain available and can support increased demand. | Available | — |
| 3. Insulatard® Penfill® and Insulatard® vials (insulin isophane human 100units/ml) remain available | Available | — |
| but cannot support any increased demand. | Available — cannot support uplift | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2024:10
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
111bdcd4b1d7a19ef9716282ceb63c4e25eddda2eabb4edfe912151a7f03b269sha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2024-10.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.